Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: May, 2019 | Pages:
115 | Publisher: MAResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
The global Therapeutic Nuclear Medicines market was valued at $XX million in 2017, and MAResearch analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2017 and 2028. This report provides detailed historical analysis of global market for Therapeutic Nuclear Medicines from 2013-2018, and provides extensive market forecasts from 2018-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Therapeutic Nuclear Medicines market. Leading players of Therapeutic Nuclear Medicines including: • Bayer • Novartis AG • China Isotope & Radiation • Dongcheng • Q BioMed • Curium Pharmaceuticals • Jubilant DraxImage • Lantheus • Spectrum Pharmaceuticals • Progenics Pharmaceuticals • International Isotopes Market split by Type, can be divided into: • Radium-223 • Lutetium-177 • Iodine-131 • Other Market split by Application, can be divided into: • Thyroid • Bone Metastasis • Lymphoma • Other Market split by Sales Channel, can be divided into: • Direct Channel • Distribution Channel Market segment by Region/Country including: • North America (United States, Canada and Mexico) • Europe (Germany, UK, France, Italy, Russia and Spain etc.) • Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) • South America Brazil, Argentina, Colombia and Chile etc.) • Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.) If you have any special requirement, please let us know and we can provide you the report as your requirement.
Table of Contents
Chapter 1 Therapeutic Nuclear Medicines Market Overview
1.1 Therapeutic Nuclear Medicines Definition
1.2 Global Therapeutic Nuclear Medicines Market Size Status and Outlook (2013-2028)
1.3 Global Therapeutic Nuclear Medicines Market Size Comparison by Region (2013-2028)
1.4 Global Therapeutic Nuclear Medicines Market Size Comparison by Type (2013-2028)
1.5 Global Therapeutic Nuclear Medicines Market Size Comparison by Application (2013-2028)
1.6 Global Therapeutic Nuclear Medicines Market Size Comparison by Sales Channel (2013-2028)
1.7 Therapeutic Nuclear Medicines Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Therapeutic Nuclear Medicines Market Segment Analysis by Player
2.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Player (2016-2018)
2.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Player (2016-2018)
2.3 Global Therapeutic Nuclear Medicines Average Price by Player (2016-2018)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Therapeutic Nuclear Medicines Market Segment Analysis by Type
3.1 Global Therapeutic Nuclear Medicines Market by Type
3.1.1 Radium-223
3.1.2 Lutetium-177
3.1.3 Iodine-131
3.1.4 Other
3.2 Global Therapeutic Nuclear Medicines Sales and Market Share by Type (2013-2018)
3.3 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2013-2018)
3.4 Global Therapeutic Nuclear Medicines Average Price by Type (2013-2018)
3.5 Leading Players of Therapeutic Nuclear Medicines by Type in 2017
3.6 Conclusion of Segment by Type
Chapter 4 Therapeutic Nuclear Medicines Market Segment Analysis by Application
4.1 Global Therapeutic Nuclear Medicines Market by Application
4.1.1 Thyroid
4.1.2 Bone Metastasis
4.1.3 Lymphoma
4.1.4 Other
4.2 Global Therapeutic Nuclear Medicines Sales and Market Share by Application (2013-2018)
4.3 Leading Consumers of Therapeutic Nuclear Medicines by Application in 2017
4.4 Conclusion of Segment by Application
Chapter 5 Therapeutic Nuclear Medicines Market Segment Analysis by Sales Channel
5.1 Global Therapeutic Nuclear Medicines Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Therapeutic Nuclear Medicines Sales and Market Share by Sales Channel (2013-2018)
5.3 Leading Distributors/Dealers of Therapeutic Nuclear Medicines by Sales Channel in 2017
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Therapeutic Nuclear Medicines Market Segment Analysis by Region
6.1 Global Therapeutic Nuclear Medicines Market Size and CAGR by Region (2013-2028)
6.2 Global Therapeutic Nuclear Medicines Sales and Market Share by Region (2013-2018)
6.3 Global Therapeutic Nuclear Medicines Revenue and Market Share by Region (2013-2018)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Therapeutic Nuclear Medicines Market Share by Type
6.4.3 North America Therapeutic Nuclear Medicines Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Therapeutic Nuclear Medicines Market Share by Type
6.5.3 Europe Therapeutic Nuclear Medicines Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Therapeutic Nuclear Medicines Market Share by Type
6.6.3 Asia-Pacific Therapeutic Nuclear Medicines Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Therapeutic Nuclear Medicines Market Share by Type in 2017
6.7.3 South America Therapeutic Nuclear Medicines Market Share by Application in 2017
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.7.7 Chile
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Therapeutic Nuclear Medicines Market Share by Type
6.8.3 Middle East & Africa Therapeutic Nuclear Medicines Market Share by Application
6.8.4 Egypt
6.8.5 Saudi Arabia
6.8.6 South Africa
6.8.7 Nigeria
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Therapeutic Nuclear Medicines Players
7.1 Bayer
7.1.1 Company Snapshot
7.1.2 Product/Business Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 Strategy and SWOT Analysis
7.2 Novartis AG
7.3 China Isotope & Radiation
7.4 Dongcheng
7.5 Q BioMed
7.6 Curium Pharmaceuticals
7.7 Jubilant DraxImage
7.8 Lantheus
7.9 Spectrum Pharmaceuticals
7.10 Progenics Pharmaceuticals
7.11 International Isotopes
Chapter 8 Upstream and Downstream Analysis of Therapeutic Nuclear Medicines
8.1 Industrial Chain of Therapeutic Nuclear Medicines
8.2 Upstream of Therapeutic Nuclear Medicines
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Therapeutic Nuclear Medicines
8.3.1 Leading Distributors/Dealers of Therapeutic Nuclear Medicines
8.3.2 Leading Consumers of Therapeutic Nuclear Medicines
Chapter 9 Development Trend of Therapeutic Nuclear Medicines (2018-2028)
9.1 Global Therapeutic Nuclear Medicines Market Size (Sales and Revenue) Forecast (2018-2028)
9.2 Global Therapeutic Nuclear Medicines Market Size and CAGR Forecast by Region (2018-2028)
9.3 Global Therapeutic Nuclear Medicines Market Size and CAGR Forecast by Type (2018-2028)
9.4 Global Therapeutic Nuclear Medicines Market Size and CAGR Forecast by Application (2018-2028)
9.5 Global Therapeutic Nuclear Medicines Market Size Forecast by Sales Channel (2018-2028)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
List of Tables and Figures
Figure Therapeutic Nuclear Medicines Example
Figure Global Therapeutic Nuclear Medicines Revenue (Million $) Status and Outlook (2013-2028)
Figure Global Therapeutic Nuclear Medicines Revenue (Million $) Comparison by Region (2013-2028)
Figure Global Therapeutic Nuclear Medicines Sales Comparison by Type (2013-2028)
Figure Global Therapeutic Nuclear Medicines Sales Comparison by Application (2013-2028)
Figure Global Therapeutic Nuclear Medicines Sales Comparison by Sales Channel (2013-2028)
Table Global Therapeutic Nuclear Medicines Sales by Player (2016-2018)
Table Global Therapeutic Nuclear Medicines Sales Market Share by Player (2016-2018)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Player in 2017
Table Global Therapeutic Nuclear Medicines Revenue (Million $) by Player (2016-2018)
Table Global Therapeutic Nuclear Medicines Revenue Market Share by Player (2016-2018)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Player in 2017
Table Global Therapeutic Nuclear Medicines Average Price by Player (2016-2018)
Figure Global Therapeutic Nuclear Medicines Average Price by Player in 2017
Figure Global Therapeutic Nuclear Medicines Players Competition Situation - Top 5 Players' Revenue Market Share in 2017
Figure Global Therapeutic Nuclear Medicines Players Competition Trends - Top 5 Players' Revenue Market Share in 2018
Figure Example of Radium-223
Figure Global Radium-223 Sales and Growth Rate (2013-2018)
Figure Example of Lutetium-177
Figure Global Lutetium-177 Sales and Growth Rate (2013-2018)
Figure Example of Iodine-131
Figure Global Iodine-131 Sales and Growth Rate (2013-2018)
Figure Example of Other
Figure Global Other Sales and Growth Rate (2013-2018)
Table Global Therapeutic Nuclear Medicines Sales by Type (2013-2018)
Table Global Therapeutic Nuclear Medicines Sales Market Share by Type (2013-2018)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Type in 2017
Table Global Therapeutic Nuclear Medicines Revenue (Million $) by Type (2013-2018)
Table Global Therapeutic Nuclear Medicines Revenue Market Share by Type (2013-2018)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Type in 2017
Table Global Therapeutic Nuclear Medicines Average Price by Type (2013-2018)
Figure Global Therapeutic Nuclear Medicines Average Price by Type in 2017
Table Leading Players of Therapeutic Nuclear Medicines by Type in 2017
Figure Example of Thyroid
Figure Global Therapeutic Nuclear Medicines for Thyroid Sales and Growth Rate (2013-2018)
Figure Example of Bone Metastasis
Figure Global Therapeutic Nuclear Medicines for Bone Metastasis Sales and Growth Rate (2013-2018)
Figure Example of Lymphoma
Figure Global Therapeutic Nuclear Medicines for Lymphoma Sales and Growth Rate (2013-2018)
Figure Example of Other
Figure Global Therapeutic Nuclear Medicines for Other Sales and Growth Rate (2013-2018)
Table Global Therapeutic Nuclear Medicines Sales by Application (2013-2018)
Table Global Therapeutic Nuclear Medicines Sales Market Share by Application (2013-2018)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Application in 2017
Table Leading Consumers of Therapeutic Nuclear Medicines by Application in 2017
Figure Example of Direct Channel
Figure Global Therapeutic Nuclear Medicines for Direct Channel Sales and Growth Rate (2013-2018)
Figure Example of Distribution Channel
Figure Global Therapeutic Nuclear Medicines for Distribution Channel Sales and Growth Rate (2013-2018)
Table Global Therapeutic Nuclear Medicines Sales by Sales Channel (2013-2018)
Table Global Therapeutic Nuclear Medicines Sales Market Share by Sales Channel (2013-2018)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Sales Channel in 2017
Table Leading Distributors/Dealers of Therapeutic Nuclear Medicines by Sales Channel in 2017
Table Global Therapeutic Nuclear Medicines Market Size and CAGR by Region (2013-2028)
Table Global Therapeutic Nuclear Medicines Sales by Region (2013-2018)
Table Global Therapeutic Nuclear Medicines Sales Market Share by Region (2013-2018)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Region in 2017
Table Global Therapeutic Nuclear Medicines Revenue (Million $) by Region (2013-2018)
Table Global Therapeutic Nuclear Medicines Revenue Market Share by Region (2013-2018)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Region in 2017
Table North America Therapeutic Nuclear Medicines Sales by Country (2013-2018)
Figure North America Therapeutic Nuclear Medicines Sales Market Share by Country (2013-2018)
Table North America Therapeutic Nuclear Medicines Revenue by Country (2013-2018)
Figure North America Therapeutic Nuclear Medicines Revenue Market Share by Country (2013-2018)
Figure North America Therapeutic Nuclear Medicines Sales Market Share by Type in 2017
Figure North America Therapeutic Nuclear Medicines Sales Market Share by Application in 2017
Figure United States Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure United States Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure Canada Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Canada Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure Mexico Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Mexico Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Table Europe Therapeutic Nuclear Medicines Sales by Country (2013-2018)
Figure Europe Therapeutic Nuclear Medicines Sales Market Share by Country (2013-2018)
Table Europe Therapeutic Nuclear Medicines Revenue by Country (2013-2018)
Figure Europe Therapeutic Nuclear Medicines Revenue Market Share by Country (2013-2018)
Figure Europe Therapeutic Nuclear Medicines Sales Market Share by Type in 2017
Figure Europe Therapeutic Nuclear Medicines Sales Market Share by Application in 2017
Figure Germany Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Germany Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure UK Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure UK Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure France Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure France Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure Italy Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Italy Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure Russia Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Russia Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure Spain Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Spain Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales by Country (2013-2018)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Country (2013-2018)
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue by Country (2013-2018)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue Market Share by Country (2013-2018)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Type in 2017
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Application in 2017
Figure China Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure China Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure Japan Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Japan Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure Korea Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Korea Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure India Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure India Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Southeast Asia Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure Australia Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Australia Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Table South America Therapeutic Nuclear Medicines Sales by Country (2013-2018)
Figure South America Therapeutic Nuclear Medicines Sales Market Share by Country (2013-2018)
Table South America Therapeutic Nuclear Medicines Revenue by Country (2013-2018)
Figure South America Therapeutic Nuclear Medicines Revenue Market Share by Country (2013-2018)
Figure South America Therapeutic Nuclear Medicines Sales Market Share by Type in 2017
Figure South America Therapeutic Nuclear Medicines Sales Market Share by Application in 2017
Figure Brazil Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Brazil Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure Argentina Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Argentina Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure Colombia Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Colombia Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure Chile Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Chile Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Table Middle East & Africa Therapeutic Nuclear Medicines Sales by Country (2013-2018)
Figure Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Country (2013-2018)
Table Middle East & Africa Therapeutic Nuclear Medicines Revenue by Country (2013-2018)
Figure Middle East & Africa Therapeutic Nuclear Medicines Revenue Market Share by Country (2013-2018)
Figure Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Type in 2017
Figure Middle East & Africa Therapeutic Nuclear Medicines Sales Market Share by Application in 2017
Figure Egypt Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Egypt Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure Saudi Arabia Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Saudi Arabia Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure South Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure South Africa Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Figure Nigeria Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2018)
Figure Nigeria Therapeutic Nuclear Medicines Revenue (Million $) and Growth Rate (2013-2018)
Table Company Snapshot of Bayer
Table Therapeutic Nuclear Medicines Introduction of Bayer
Table Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share of Bayer (2016-2018)
Table Industrial Chain of Therapeutic Nuclear Medicines
Table Manufacturing Cost Structure of Therapeutic Nuclear Medicines
Table General Manufacturing Process of Therapeutic Nuclear Medicines
Table Leading Distributors/Dealers of Therapeutic Nuclear Medicines
Table Leading Consumers of Therapeutic Nuclear Medicines
Figure Global Therapeutic Nuclear Medicines Sales and Growth Rate Forecast (2018-2028)
Figure Global Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2018-2028)
Table Global Therapeutic Nuclear Medicines Market Size and CAGR Forecast by Region (2018-2028)
Table Global Therapeutic Nuclear Medicines Market Size and CAGR Forecast by Type (2018-2028)
Table Global Therapeutic Nuclear Medicines Market Size and CAGR Forecast by Application (2018-2028)
Table Global Therapeutic Nuclear Medicines Market Size and CAGR Forecast by Sales Channel (2018-2028) 
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
